COMP <GO>
CNR vs CVX // REVENUE GROWTH (YOY)
Core Natural Resources Inc. (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: CNR 1
— CVX 9
▲ REVENUE GROWTH (YOY) LEADER: CNR
LAST: $86.93 (-0.25%) • MKT CAP: $4.33B
revenue-growth
92.40%
LAST: $235.52 (+1.75%) • MKT CAP: $457.31B
revenue-growth
-4.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNR VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNR | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 41.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.00% | 5.80% | -9.80 | CVX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 21.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.49% | 5.61% | -5.12 | CVX | /fcf-yield <GO> |
| Operating Margin | -4.40% | 8.10% | -12.50 | CVX | /operating-margins <GO> |
| Net Profit Margin | -3.70% | 6.70% | -10.40 | CVX | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 92.40% | -4.60% | +97.00 | CNR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.61% | 2.79% | -2.18 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.93 | 3.71 | -1.78 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | CVX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.8 | 64.7 | -20.90 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.07 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 34.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.33B | $457.31B | -$452.99B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNR REV | CVX REV | CNR GROSS % | CVX GROSS % | CNR FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.16B | $184.43B | — | 41.3% | $21.2M | $25.64B |
| FY 2024 | $2.16B | $193.41B | — | 38.4% | $298.4M | $22.79B |
| FY 2023 | $2.51B | $196.91B | — | — | $857.9M | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNR // BETA —
CVX // BETA 1.07